FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213009671> ?p ?o ?g. }

• W4213009671 endingPage "1738" @default.
• W4213009671 startingPage "1731" @default.
• W4213009671 abstract "Ribosomal S6 kinase has been shown to play a key role in cellular resistance to endocrine therapy in prostate cancer through its regulation of YB-1/androgen receptor (AR) signaling. PMD-026, an oral first-in-class small molecule kinase inhibitor, is the first identified ribosomal S6 kinase inhibitor. This study investigated the effect of PMD-026 on YB-1/AR signaling and its antitumor effect in prostate cancer in vitro and in vivo. Castration-resistant prostate cancer 22Rv1 cells that express high-level AR variants were used in this study. The effect of PMD-026 on YB-1/AR signaling was investigated by quantitative real-time PCR and western blot analysis. The effects of PMD-026 on prostate cancer cells were investigated by cytotoxicity analysis, apoptosis assay, and cell cycle assay in vitro and a mouse castration model in vivo. PMD-026 decreased YB-1 phosphorylation as well as AR V7 mRNA and AR variant expressions in 22Rv1 cells. PMD-026 suppressed cell proliferation alone and in combination with the second-generation antiandrogens enzalutamide and darolutamide by inducing cellular apoptosis and G2/M arrest. In a mouse xenograft model, PMD-026 suppressed tumor growth, and the combination of PMD-026 and enzalutamide inhibited tumor growth more prominently than single treatments. Our results demonstrate an excellent antitumor effect of the novel ribosomal S6 kinase inhibitor PMD-026 and the combination effect with the antiandrogen enzalutamide in castration-resistant prostate cancer. These findings warrant a clinical trial of PMD-026 in prostate cancer patients." @default.
• W4213009671 created "2022-02-24" @default.
• W4213009671 creator A5000508958 @default.
• W4213009671 creator A5003021924 @default.
• W4213009671 creator A5015753910 @default.
• W4213009671 creator A5044851719 @default.
• W4213009671 creator A5064422624 @default.
• W4213009671 creator A5078149945 @default.
• W4213009671 date "2022-04-01" @default.
• W4213009671 modified "2023-10-16" @default.
• W4213009671 title "An oral first‐in‐class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer" @default.
• W4213009671 cites W1625702540 @default.
• W4213009671 cites W1915769685 @default.
• W4213009671 cites W1995333503 @default.
• W4213009671 cites W2032431432 @default.
• W4213009671 cites W2055489382 @default.
• W4213009671 cites W2069824527 @default.
• W4213009671 cites W2089855272 @default.
• W4213009671 cites W2102051933 @default.
• W4213009671 cites W2120012330 @default.
• W4213009671 cites W2122472408 @default.
• W4213009671 cites W2124864765 @default.
• W4213009671 cites W2147429680 @default.
• W4213009671 cites W2160683570 @default.
• W4213009671 cites W2267290488 @default.
• W4213009671 cites W2314600973 @default.
• W4213009671 cites W2324289718 @default.
• W4213009671 cites W2510331075 @default.
• W4213009671 cites W3014043383 @default.
• W4213009671 cites W3131816550 @default.
• W4213009671 cites W3145062445 @default.
• W4213009671 cites W3159923585 @default.
• W4213009671 cites W3180124556 @default.
• W4213009671 cites W3180572238 @default.
• W4213009671 cites W4213009671 @default.
• W4213009671 doi "https://doi.org/10.1111/cas.15280" @default.
• W4213009671 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35118769" @default.
• W4213009671 hasPublicationYear "2022" @default.
• W4213009671 type Work @default.
• W4213009671 citedByCount "7" @default.
• W4213009671 countsByYear W42130096712022 @default.
• W4213009671 countsByYear W42130096712023 @default.
• W4213009671 crossrefType "journal-article" @default.
• W4213009671 hasAuthorship W4213009671A5000508958 @default.
• W4213009671 hasAuthorship W4213009671A5003021924 @default.
• W4213009671 hasAuthorship W4213009671A5015753910 @default.
• W4213009671 hasAuthorship W4213009671A5044851719 @default.
• W4213009671 hasAuthorship W4213009671A5064422624 @default.
• W4213009671 hasAuthorship W4213009671A5078149945 @default.
• W4213009671 hasBestOaLocation W42130096712 @default.
• W4213009671 hasConcept C104202773 @default.
• W4213009671 hasConcept C121608353 @default.
• W4213009671 hasConcept C126322002 @default.
• W4213009671 hasConcept C150903083 @default.
• W4213009671 hasConcept C184235292 @default.
• W4213009671 hasConcept C185592680 @default.
• W4213009671 hasConcept C190283241 @default.
• W4213009671 hasConcept C207001950 @default.
• W4213009671 hasConcept C2776551883 @default.
• W4213009671 hasConcept C2779723316 @default.
• W4213009671 hasConcept C2780044377 @default.
• W4213009671 hasConcept C2780192828 @default.
• W4213009671 hasConcept C2910016293 @default.
• W4213009671 hasConcept C502942594 @default.
• W4213009671 hasConcept C55493867 @default.
• W4213009671 hasConcept C61367390 @default.
• W4213009671 hasConcept C62112901 @default.
• W4213009671 hasConcept C71924100 @default.
• W4213009671 hasConcept C75217442 @default.
• W4213009671 hasConcept C86803240 @default.
• W4213009671 hasConcept C95444343 @default.
• W4213009671 hasConceptScore W4213009671C104202773 @default.
• W4213009671 hasConceptScore W4213009671C121608353 @default.
• W4213009671 hasConceptScore W4213009671C126322002 @default.
• W4213009671 hasConceptScore W4213009671C150903083 @default.
• W4213009671 hasConceptScore W4213009671C184235292 @default.
• W4213009671 hasConceptScore W4213009671C185592680 @default.
• W4213009671 hasConceptScore W4213009671C190283241 @default.
• W4213009671 hasConceptScore W4213009671C207001950 @default.
• W4213009671 hasConceptScore W4213009671C2776551883 @default.
• W4213009671 hasConceptScore W4213009671C2779723316 @default.
• W4213009671 hasConceptScore W4213009671C2780044377 @default.
• W4213009671 hasConceptScore W4213009671C2780192828 @default.
• W4213009671 hasConceptScore W4213009671C2910016293 @default.
• W4213009671 hasConceptScore W4213009671C502942594 @default.
• W4213009671 hasConceptScore W4213009671C55493867 @default.
• W4213009671 hasConceptScore W4213009671C61367390 @default.
• W4213009671 hasConceptScore W4213009671C62112901 @default.
• W4213009671 hasConceptScore W4213009671C71924100 @default.
• W4213009671 hasConceptScore W4213009671C75217442 @default.
• W4213009671 hasConceptScore W4213009671C86803240 @default.
• W4213009671 hasConceptScore W4213009671C95444343 @default.
• W4213009671 hasFunder F4320320212 @default.
• W4213009671 hasIssue "5" @default.
• W4213009671 hasLocation W42130096711 @default.
• W4213009671 hasLocation W42130096712 @default.
• W4213009671 hasLocation W42130096713 @default.
• W4213009671 hasOpenAccess W4213009671 @default.

• next